Center-Authored Papers

Filters: Author is Shannon-Dorcy, Kathleen  [Clear All Filters]
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
2011
Shannon-Dorcy K, Drevdahl DJ.  2011.  "I had already made up my mind": patients and caregivers' perspectives on making the decision to participate in research at a US cancer referral center.. Cancer nursing. 34(6):428-33. Abstract
Walter RB, Lee SJ, Gardner KM, Chai X, Shannon-Dorcy K, Appelbaum FR, Estey EH.  2011.  Outpatient management following intensive induction chemotherapy for myelodysplastic syndromes and acute myeloid leukemia: a pilot study.. Haematologica. 96(6):914-7. Abstract
2014
Lionberger JM, Pagel JM, Sandhu VK, Xie H, Shadman M, Mawad R, Boehm A, Dean C, Shannon-Dorcy K, Scott BL et al..  2014.  Outpatient bendamustine and idarubicin for upfront therapy of elderly acute myeloid leukaemia/myelodysplastic syndrome: a phase I/II study using an innovative statistical design.. British journal of haematology. 166(3):375-81. Abstract
Center-Authored Paper
Walter RB, Lee SJ, Gardner KM, Chai X, Shannon-Dorcy K, Appelbaum FR, Estey EH.  2011.  Outpatient management following intensive induction chemotherapy for myelodysplastic syndromes and acute myeloid leukemia: a pilot study.. Haematologica. 96(6):914-7. Abstract
Lionberger JM, Pagel JM, Sandhu VK, Xie H, Shadman M, Mawad R, Boehm A, Dean C, Shannon-Dorcy K, Scott BL et al..  2014.  Outpatient bendamustine and idarubicin for upfront therapy of elderly acute myeloid leukaemia/myelodysplastic syndrome: a phase I/II study using an innovative statistical design.. British journal of haematology. 166(3):375-81. Abstract
Clinical Research Division
Walter RB, Lee SJ, Gardner KM, Chai X, Shannon-Dorcy K, Appelbaum FR, Estey EH.  2011.  Outpatient management following intensive induction chemotherapy for myelodysplastic syndromes and acute myeloid leukemia: a pilot study.. Haematologica. 96(6):914-7. Abstract
Lionberger JM, Pagel JM, Sandhu VK, Xie H, Shadman M, Mawad R, Boehm A, Dean C, Shannon-Dorcy K, Scott BL et al..  2014.  Outpatient bendamustine and idarubicin for upfront therapy of elderly acute myeloid leukaemia/myelodysplastic syndrome: a phase I/II study using an innovative statistical design.. British journal of haematology. 166(3):375-81. Abstract
Shannon-Dorcy K, Drevdahl DJ.  2011.  "I had already made up my mind": patients and caregivers' perspectives on making the decision to participate in research at a US cancer referral center.. Cancer nursing. 34(6):428-33. Abstract
December 2011
Shannon-Dorcy K, Drevdahl DJ.  2011.  "I had already made up my mind": patients and caregivers' perspectives on making the decision to participate in research at a US cancer referral center.. Cancer nursing. 34(6):428-33. Abstract
Flow Cytometry Core Facility
Lionberger JM, Pagel JM, Sandhu VK, Xie H, Shadman M, Mawad R, Boehm A, Dean C, Shannon-Dorcy K, Scott BL et al..  2014.  Outpatient bendamustine and idarubicin for upfront therapy of elderly acute myeloid leukaemia/myelodysplastic syndrome: a phase I/II study using an innovative statistical design.. British journal of haematology. 166(3):375-81. Abstract
May 2014
Lionberger JM, Pagel JM, Sandhu VK, Xie H, Shadman M, Mawad R, Boehm A, Dean C, Shannon-Dorcy K, Scott BL et al..  2014.  Outpatient bendamustine and idarubicin for upfront therapy of elderly acute myeloid leukaemia/myelodysplastic syndrome: a phase I/II study using an innovative statistical design.. British journal of haematology. 166(3):375-81. Abstract
Research Trials Office Core Facility - Biostatistics Service
Lionberger JM, Pagel JM, Sandhu VK, Xie H, Shadman M, Mawad R, Boehm A, Dean C, Shannon-Dorcy K, Scott BL et al..  2014.  Outpatient bendamustine and idarubicin for upfront therapy of elderly acute myeloid leukaemia/myelodysplastic syndrome: a phase I/II study using an innovative statistical design.. British journal of haematology. 166(3):375-81. Abstract
Walter RB, Lee SJ, Gardner KM, Chai X, Shannon-Dorcy K, Appelbaum FR, Estey EH.  2011.  Outpatient management following intensive induction chemotherapy for myelodysplastic syndromes and acute myeloid leukemia: a pilot study.. Haematologica. 96(6):914-7. Abstract
Shared Resources
Walter RB, Lee SJ, Gardner KM, Chai X, Shannon-Dorcy K, Appelbaum FR, Estey EH.  2011.  Outpatient management following intensive induction chemotherapy for myelodysplastic syndromes and acute myeloid leukemia: a pilot study.. Haematologica. 96(6):914-7. Abstract
Specimen Processing Core Facility
Shadman M, Mawad R, Dean C, Chen TL, Shannon-Dorcy K, Sandhu V, Hendrie PC, Scott BL, Walter RB, Becker PS et al..  2015.  Idarubicin, cytarabine, and pravastatin as induction therapy for untreated acute myeloid leukemia and high-risk myelodysplastic syndrome.. American journal of hematology. 90(6):483-6. Abstract
Lionberger JM, Pagel JM, Sandhu VK, Xie H, Shadman M, Mawad R, Boehm A, Dean C, Shannon-Dorcy K, Scott BL et al..  2014.  Outpatient bendamustine and idarubicin for upfront therapy of elderly acute myeloid leukaemia/myelodysplastic syndrome: a phase I/II study using an innovative statistical design.. British journal of haematology. 166(3):375-81. Abstract